RBR. Michael Bagby

R. Michael Bagby

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


R. Michael Bagby has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Beyond “somatization” and “psychologization”: symptom-level variation in depressed Han Chinese and Euro-Canadian outpatients

    by Jessica Dere, Jiahong Sun, Yue Zhao, Tonje J. Persson, Xiongzhao Zhu, Shuqiao Yao, R. Michael Bagby, Andrew G. Ryder

    The finding that people of Chinese heritage tend to emphasize somatic rather than psychological symptoms of depression has frequently been discussed in the culture and mental health literature since the 1970s. Recent studies have confirmed that Chinese samples report more somatic and fewer psychological depression symptoms compared to “Western” samples. The question remains, however, as to whether or not these effects are attributable to variation in all the constituent symptoms or to a subset. If the latter, there is the additional possibility that some symptoms might show a divergent pattern. Such findings would have implications for how cultural variations in symptom presentation are interpreted, and would also inform the cultural study of affective experiences more broadly. The current study addressed these issues in Chinese (n = 175) and Euro-Canadian (n = 107) psychiatric outpatients originally described by Ryder et al. (2008). Differential item functioning (DIF) was used to examine whether specific somatic and psychological symptoms diverged from the overall patterns of cultural variation. Chi-square analyses were used to examine atypical somatic symptoms (e.g., hypersomnia), previously neglected in this literature. No DIF was observed for the typical somatic symptoms, but Euro-Canadians reported greater levels of atypical somatic symptoms, and showed higher rates of atypical depression. DIF was observed for psychological symptoms—the Chinese reported high levels of “suppressed emotions” and “depressed mood,” relative to their overall psychological symptom reporting. Chinese outpatients also spontaneously reported “depressed mood” at similar levels as the Euro-Canadians, contrary to prevailing ideas about Chinese unwillingness to discuss depression. Overall, the findings provide a more nuanced picture of how culture shapes symptom presentation and point toward future studies designed to unpack cultural variation in narrower subsets of depressive symptoms.


  • Depressive Personality Disorder

    by R. Michael Bagby, Chris Watson, Andrew G. Ryder

    This chapter provides an overview of depressive personality disorder, including its history, conceptualization within the American Psychiatric Association’s diagnostic manual, prevalence rates, etiology, characteristics, course, comorbidity with dysthymia and other disorders, and a review of the various instruments that can be used for its assessment. Also discussed is the dimensional approach to personality and its applicability to this disorder, and the impact of depressive personality disorder on the treatment of other psychological difficulties, such as major depressive disorder. This chapter ends with an update of the status of depressive personality disorder in DSM-5 and our recommendations for ways to maintain depressive personality traits in future editions of the diagnostic manual.

  • Depressive Personality and Treatment Outcome in Major Depressive Disorder

    by Andrew G. Ryder, Lena C. Quilty, David D. Vachon, R. Michael Bagby

    Depressive personality disorder (DPD) is currently included in the DSM-IV Appendix B, Criteria Sets and Axes Provided for Further Study. Evidence of the clinical utility of DPD will likely play an important role in the determination of whether it warrants inclusion in future editions of DSM. The current investigation examines the capacity of DPD traits to predict overall and preferential treatment outcome for patients with Major Depressive Disorder (MDD) (N = 120) using data from a randomized control trial, which included cognitive behavioral therapy (CBT), interpersonal therapy (IPT), and antidepressant medication (ADM) treatment arms. Patients were treated for 16-20 weeks and completed the Structured Clinical Interview for DSM-IV Axis II Personality Disorders Questionnaire (SCID-II/PQ) and the 17-item Hamilton Rating Scale for Depression immediately before and after treatment. Higher scores on a dimensionalized SCID-II/PQ subscale assessing DPD traits were associated with poor outcome for IPT, but not CBT or ADM. This result remained after accounting for variance associated with other personality disorder (PD) traits; none of the other 10 main text PDs predicted treatment outcome.